Abstract:Objective:To investigate the mechanism of inhibition of inflammation in osteoarthritis by Tougu Xiaotong capsule(TXC)via regulating Ras-Raf-MEK1/2-ERK1/2 signaling pathways.Methods:The chondrocytes from 4-week-old SD male rats obtained by the mechanical typeⅡcollagenase digestion method were cultured in vitro and identified by typeⅡcollagen immunohistochemical staining. Isolated chondrocytes of passage two were divided into blank group, model group(treatment with 10 ng/mL of LPS for 8 h), inhibitor group(treatment with 10 ng/mL of U0126 for 30 min followed by 10 ng/mL of LPS for additional 8 h)and TXC group(treatment with 10 ng/mL of LPS plus 300 μg/mL of TXC for 8 h).Western blot was carried out to detect the expression of Ras, Raf, p-ERK1/2, MEK1/2, MMP-3 and MMP-13.qPCR was used to detect the mRNAs expression of MEK1/2, ERK1/2, MMP-3 and MMP-13, as well as the expression of miR-27b, miR-34a and miR-146a.Results:1)The cytoplasm of isolated cells(P2)from the cartilage of knee joint of 4-week-old SD male rats was stained brown by typeⅡcollagen immunohistochemical staining as compared with the negative control cells, which indicated that the extracted cells were chondrocytes.2)The expression of Ras, Raf, MEK1/2, MMP-3, MMP-13 in the model group was significantly higher than that in the blank group, respectively(P<0.01, P<0.05), but the expression of p-ERK1/2 had no significant difference(P>0.05);the expression of Ras, Raf, p-ERK1/2, MEK1/2, MMP-3, MMP-13 in both the inhibitor group and the TXC group was lower than that in the model group, respectively(P<0.01, P<0.05), but the expression of MEK1/2 in the TXC group had no significant difference compared to that in the model group(P>0.05).3)The mRNA expression of MEK1/2, ERK1/2, MMP-3 and MMP-13 in the model group was significantly higher than that in the blank group, respectively(P<0.01);their expression in both the inhibitor group and the TXC group was lower than that in the model group, respectively(P<0.01, P<0.05).4)The expression of miR-27b in the model group was significantly lower than that in the blank group(P<0.01), but its expre-ssion in both the inhibitor group and the TXC group was higher than that in the model group(P<0.01);the expression of both miR-34a and miR-146a in the model group was significantly higher than that in the blank group, respectively(P<0.01, P<0.05);however, their expression in both the inhibitor group and the TXC group was lower than that in the model group, respectively(P<0.01, P<0.05).Conclusion:Tougu Xiaotong capsule regulates the expression of key factors in Ras-Raf-MEK1/2-ERK1/2 signaling pathway and miR-27b, miR-34a and miR-146a to regulate the inflammatory of chondrocytes, thereby inhibiting osteoarthritis inflammation and protecting articular cartilage.

Pharmacological Research on Osteoarthritis Treated by Tougu Xiaotong Capsule

Computational pharmacology study of tougu xiaotong granule in preventing and treating knee osteoarthritis.

Chemical Space Analysis of Tougu Xiaotong Capsule in Preventing and Treating Osteoarthritis

Network Pharmacology and Molecular Docking to Elucidate the Potential Mechanism of Ligusticum Chuanxiong Against Osteoarthritis

Network Pharmacology-Based Approach to Investigate the Active Ingredients and Therapeutic Mechanisms of Jingu Tongxiao Pill Against Osteoarthritis.

Comparison of the mode of action of Bushen Rougan(补肾柔肝)drugs versus Huoxue Qufeng(活血祛风) drugs contained in Tougu Xiaotong Jiaonang(透骨消痛胶囊)for the treatment of osteoarthritis:A computer simulation study

Exploration of the mechanism of tetramethoxyflavone in treating osteoarthritis based on network pharmacology and molecular docking

Components Simulation Analysis of Tougu Xiaotong Granule in Preventing and Treating Intraosseous Hypertension of Knee Osteoarthritis

Study on the Mechanism of Action of the Traditional Chinese Medical Prescription Gushukang in Treating Osteoporosis Based on Network Pharmacology and Experimental Verification

Network pharmacology and molecular docking approach to investigate the mechanism of a Chinese herbal formulation Yougui pills against steroid-related osteonecrosis of the femoral head

Bioinformatics analysis combined with experimental validation to explore the mechanism of XianLing GuBao capsule against osteoarthritis

Systematic elucidation of the traditional Chinese medicine prescription Danxiong particles via network pharmacology and molecular docking

Study on the Mechanism of Baimai Ointment in the Treatment of Osteoarthritis Based on Network Pharmacology and Molecular Docking with Experimental Verification

Mechanism of Inhibition of Inflammation in Osteoarthritis by Tougu Xiaotong Capsule Via Regulating Ras-Raf-MEK1/2-ERK1/2 Signaling Pathway

The Underlying Mechanism of Chinese Herb of Regulating Marrow in the Treatment of Osteonecrosis of the Femoral Head Based on Network Pharmacology and Molecular Docking

Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Duhuo–Jisheng pair against osteoarthritis

Experimental evidence and Network Pharmacology-based analysis reveal the Molecular Mechanism of Tongxinluo capsule administered in Coronary Heart Diseases

Network Pharmacology-Based Prediction of the Multi-Target Capabilities of the Compounds in Taohong Siwu Decoction, and Their Application in Osteoarthritis

Discussion on Polypharmacology of Haitongpi Decoction in Treatment of Osteoarthritis

A New Practice: Study on the Molecular Mechanism of Traditional Chinese Medicine by Computational Pharmacology Methods: Part 2: Pharmacodynamic Modeling and Distribution on Ligand-Target Space of Effective Components

The Possibility of Polygonum cuspidatum against Osteoarthritis based on Network Pharmacology